Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gallo

Showing results (831-840 of 1,331) with videos related to

Pageof 134
Sort By:
Progress in Community Health Partnerships : Research, Education, and Action|December 2, 2014
A three-decade evolution to transdisciplinary research: community health research in California-Mexico border communitiesJohn P Elder, Guadalupe X Ayala, Thomas L McKenzie, et al.
AIDS Research and Human Retroviruses|June 1, 1992
Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1F di Marzo Veronese, R Rahman, R Pal, et al.
Journal of Virological Methods|September 1, 1988
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromesG R Krueger, B Koch, A Ramon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2000
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaquesC D Pauza, P Trivedi, M Wallace, et al.
Annals of Internal Medicine|April 1, 1986
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal studyM Melbye, R J Biggar, P Ebbesen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virusT H Lee, J E Coligan, M F McLane, et al.
Cancer|April 1, 1988
Molecular epidemiology of HTLV-I-associated non-Hodgkin's lymphomas in JamaicaJ W Clark, C Gurgo, G Franchini, et al.
Oncology|January 1, 1980
Immunologic monitoring during combined radiochemoimmunotherapy in inoperable lung cancerE Sega, M Rinaldi, M Mottolese, et al.
Nature|August 4, 1988
Biologically diverse molecular variants within a single HIV-1 isolateA G Fisher, B Ensoli, D Looney, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriersZ N Berneman, R B Gartenhaus, M S Reitz, et al.
Pageof 134

Showing results (831-840 of 1,331) with videos related to

Sort By:
Pageof 134
Progress in Community Health Partnerships : Research, Education, and Action|December 2, 2014
A three-decade evolution to transdisciplinary research: community health research in California-Mexico border communitiesJohn P Elder, Guadalupe X Ayala, Thomas L McKenzie, et al.
AIDS Research and Human Retroviruses|June 1, 1992
Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1F di Marzo Veronese, R Rahman, R Pal, et al.
Journal of Virological Methods|September 1, 1988
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromesG R Krueger, B Koch, A Ramon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2000
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaquesC D Pauza, P Trivedi, M Wallace, et al.
Annals of Internal Medicine|April 1, 1986
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal studyM Melbye, R J Biggar, P Ebbesen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virusT H Lee, J E Coligan, M F McLane, et al.
Cancer|April 1, 1988
Molecular epidemiology of HTLV-I-associated non-Hodgkin's lymphomas in JamaicaJ W Clark, C Gurgo, G Franchini, et al.
Oncology|January 1, 1980
Immunologic monitoring during combined radiochemoimmunotherapy in inoperable lung cancerE Sega, M Rinaldi, M Mottolese, et al.
Nature|August 4, 1988
Biologically diverse molecular variants within a single HIV-1 isolateA G Fisher, B Ensoli, D Looney, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriersZ N Berneman, R B Gartenhaus, M S Reitz, et al.
Pageof 134